(Q42829379)

8 November 2017

title

Association of ErbB2 Ser1113 phosphorylation with epidermal growth factor receptor co-expression and poor prognosis in human breast cancer (English)

1 reference

8 November 2017

1 reference

X Ouyang

1

1 reference

8 November 2017

T Gulliford

2

1 reference

8 November 2017

H Zhang

3

1 reference

8 November 2017

G Smith

4

1 reference

8 November 2017

G Huang

5

1 reference

8 November 2017

R J Epstein

6

1 reference

8 November 2017

publication date

1 February 2001

1 reference

Molecular and Cellular Biochemistry

8 November 2017

published in

1 reference

8 November 2017

volume

218

1 reference

8 November 2017

issue

1-2

1 reference

8 November 2017

page(s)

47-54

1 reference

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

8 November 2017

cites work

1 reference

12 December 2020

Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction

1 reference

12 December 2020

Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer

1 reference

12 December 2020

Negative Feedback Regulation and Desensitization of Insulin- and Epidermal Growth Factor-stimulated p21ras Activation

1 reference

12 December 2020

Detection of ErbB2 oversignalling in a majority of breast cancers with phosphorylation-state-specific antibodies

1 reference

12 December 2020

Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor

1 reference

12 December 2020

Superagonistic behaviour of epidermal growth factor/transforming growth factor-alpha chimaeras: correlation with receptor routing after ligand-induced internalization

1 reference

12 December 2020

Increased oncogenic potential of ErbB is associated with the loss of a COOH-terminal domain serine phosphorylation site

1 reference

12 December 2020

Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Transforming growth factor-alpha short-circuits downregulation of the epidermal growth factor receptor

1 reference

12 December 2020

Multisite phosphorylation of the epidermal growth factor receptor. Use of site-directed mutagenesis to examine the role of serine/threonine phosphorylation

1 reference

12 December 2020

EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene

1 reference

12 December 2020

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

12 December 2020

A point mutation in the neu oncogene mimics ligand induction of receptor aggregation

1 reference

12 December 2020

Preferential detection of catalytically inactive c-erbB-2 by antibodies to unphosphorylated peptides mimicking receptor tyrosine autophosphorylation sites

1 reference

12 December 2020

Signal transduction by the epidermal growth factor receptor is attenuated by a COOH-terminal domain serine phosphorylation site.

1 reference

12 December 2020

Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms

1 reference

12 December 2020

Adjacent carboxyterminal tyrosine phosphorylation events identify functionally distinct ErbB2 receptor subsets: implications for molecular diagnostics

1 reference

12 December 2020

Platelet-derived growth factor mimics phorbol diester action on epidermal growth factor receptor phosphorylation at threonine-654

1 reference

12 December 2020

Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformation

1 reference

12 December 2020

Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2

1 reference

12 December 2020

Human cancer cells exhibit protein kinase C-dependent c-erbB-2 transmodulation that correlates with phosphatase sensitivity and kinase activity

1 reference

12 December 2020

Serine 1002 is a site of in vivo and in vitro phosphorylation of the epidermal growth factor receptor

1 reference

12 December 2020

GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction

1 reference

12 December 2020

Okadaic acid-induced hyperphosphorylation of the epidermal growth factor receptor. Comparison with receptor phosphorylation and functions affected by another tumor promoter, 12-O-tetradecanoylphorbol-13-acetate

1 reference

12 December 2020

Overexpression of ErbB2 impairs ligand-dependent downregulation of epidermal growth factor receptors via a post-transcriptional mechanism

1 reference

12 December 2020

Mechanism of desensitization of the epidermal growth factor receptor protein-tyrosine kinase

1 reference

12 December 2020

Tumor-promoting phorbol diesters cause the phosphorylation of epidermal growth factor receptors in normal human fibroblasts at threonine-654

1 reference

12 December 2020

HER-2/c-erbB2 is phosphorylated by calmodulin-dependent protein kinase II on a single site in the cytoplasmic tail at threonine-1172

1 reference

12 December 2020

Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene

1 reference

12 December 2020

Immunodetection of the Ligand-Activated Receptor for Epidermal Growth Factor

1 reference

12 December 2020

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1007249004222

1 reference

Dimensions Publication ID

8 November 2017

1042536841

0 references

1 reference